TGFB1 and neoplasm: In addition to utilizing immunostimulatory cytokines and their agonists, antagonizing immunosuppressive ones can also augment anti-tumor immunity, as exemplified by agents targeting transforming growth factor-β (TGF-β) (Fig. 5a).